BOSTON--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ: OFIX) announced today that the Musculoskeletal Transplant Foundation (MTF) has completed the major milestone in the development of a next-generation stem cell allograft. With the completion of this pivotal phase, MTF has successfully delivered to Orthofix a conclusive data package meeting the specifications provided by Orthofix under the parties’ Development Agreement. The full commercialization of this tissue form, called Trinity Evolution™, is ahead of schedule and is now expected by June 2009.
